Buyers are hot on second homes, but lenders aren't
As the dramatic events in Washington, D.C. were unfolding Wednesday, the coroanvirus-borne illness COVID-19 continued to wreak havoc in the U.S., claiming a record of almost 4,000 American lives, the most in a single day since the start of the outbre...
London-listed Hipgnosis, founded by Merck Mercuriadis, strikes third deal in days.
The fewer stocks you own, the riskier your approach
U.K. stocks struggled for direction on Thursday, one day after the FTSE 100's biggest advance in close to three months.
Gold futures stage a partial rebound on Thursday, day after rising U.S. bond yields prompted the metal, which doesn't offer a coupon, to post its first loss in six sessions.
Johnson & Johnson's vaccine candidate, which is being developed by its Belgium-based division Janssen, could be authorized for use by next month.
U.S. stock benchmarks surge Thursday morning, with gains accelerating and pushing indexes to a series of milestones, after a report on services activity came in hotter than expected.
